TIDMDKE
RNS Number : 7034N
Dukemount Capital PLC
11 August 2017
11 August 2017
Dukemount Capital Plc
("Dukemount" or the "Company")
Final Results for the year ended 30 April 2017
Dukemount Capital Plc (LSE: DKE), a business formed for the
purpose of acquiring, developing and managing real estate
portfolios specialising mainly in the supported living and hotels
sector, reports its Final Results for the year ended 30 April
2017.
All financial amounts are stated in GBP British pounds unless
otherwise indicated.
Chairman's Statement
I hereby present the annual financial statements for the year
ended 30(th) April 2017. During the year the Company reported a
loss of GBP177,149 (30 April 2016 - loss of GBP46,077) which arose
predominantly from professional fees in connection with the
admission of the Ordinary Shares of the Company to the Official
List of the UK Listing Authority by way of a standard listing on
29(th) March 2017. As at the Statement of Financial Position date
the Company had GBP593,406 of cash balances.
Following its listing, the Company has continued to focus on
completing a transaction in the supported living property sector
which may likely involve institutional investors and a joint
venture with a financial partner within its stated area of the
supported living and hotel sectors. The target areas include the
acquisition, development and/or management of a portfolio of
properties. The Company informed the Market on 25(th) May 2017, and
again on 7(th) August, of its agreement with a Housing Association
to identify suitable properties. The Board continues to review a
number of projects and will make further announcements on progress
once it is appropriate to do so.
I would like to thank all those who have assisted in relation to
the recent listing including the shareholders for their support and
look forward to a positive year ahead.
Geoffrey Dart
Executive Chairman
Statement of Comprehensive Income
Note 2017 2016
Continuing operations GBP GBP
Revenue - -
Administrative expenses 11 (167,470) (46,077)
_______ _____
Operating loss (167,470) (46,077)
Loss on disposal of available
for sale financial asset 6 (9,679) -
_______ _____
Loss before taxation (177,149) (46,077)
Income tax 3 - -
_______ _____
Loss for the year attributable
to equity owners (177,149) (46,077)
_______ _____
Other Comprehensive Income:
Items that may be subsequently
reclassified to profit or loss:
Change in fair value of available
for sale financial assets 6 800 (6,400)
Reclassification of cumulative
loss on available for sale
financial assets on disposal 6 17,200 -
_______ _____
Total comprehensive income
for the year attributable to
the equity owners (159,149) (52,477)
_______ _____
Earnings per share attributable
to equity owners
Basic and diluted (pence) 5 (0.099) (0.030)
_______ _____
The notes to the financial statements form an integral part of
these financial statements.
Statement of Financial Position
Company Registration Number: 08401609
Note 30 April 30 April
2017 2016
GBP GBP
Assets
Current Assets
Available for sale financial
assets 6 25,000 27,000
Trade and other receivables 7 41,793 3,926
Cash and cash equivalents 593,406 37,369
_______ _______
Total Assets 660,199 68,295
_______ _______
Equity and Liabilities
Equity
Share capital 8 338,300 152,500
Share premium 9 731,537 196,500
Share based payments reserve 30,499 23,308
Retained earnings (467,012) (307,863)
_______ _______
633,324 64,445
Current Liabilities
Trade and other payables 14 26,875 3,850
_______ _______
Total Equity and Liabilities 660,199 68,295
_______ _______
The notes to the financial statements form an integral part of
these financial statements.
Statement of Changes in Equity
Attributable to equity shareholders
Share Share Share Retained Total
Capital premium based earnings
payments
reserve
GBP GBP GBP GBP GBP
Balance as at 1 May
2015 152,500 196,500 23,308 (255,386) 116,922
______ _______ ______ _______ _______
Loss for the year - - - (46,077) (46,077)
Other comprehensive
income
Change in fair value
of available for sale
financial assets - - - (6,400) (6,400)
______ _______ ______ _______ _______
Total comprehensive
income for the year - - - (52,477) (52,477)
______ _______ ______ _______ _______
Balance as at 30 April
2016 152,500 196,500 23,308 (307,863) 64,445
______ _______ ______ _______ _______
Loss for the year - - - (177,149) (177,149)
Other comprehensive
Income
Change in fair value
of available for sale
financial assets - - - 800 800
Reclassification of
cumulative loss on available
for sale financial assets
on disposal - - - 17,200 17,200
______ _______ _______ _______ _______
Total comprehensive
income for the year - - - (159,149) (159,149)
______ _______ _______ _______ _______
Issue of ordinary shares 185,800 623,200 - - 809,000
Issue costs - (88,163) - - (88,163)
Share based payments - - 7,191 - 7,191
______ _______ _______ _______ _______
Total transactions with
owners 185,800 535,037 7,191 - 728,028
______ _______ _______ _______ _______
Balance as at 30 April
2017 338,300 731,537 30,499 (467,012) 633,324
______ _______ _______ _______ _______
Share capital comprises the ordinary issued share capital of the
Company.
Share Premium represents consideration less nominal value of
issued shares and costs directly attributable to the issue of new
shares.
Share based payments reserve represents the fair value of share
based payments valued in accordance with IFRS 2.
Retained earnings represent the cumulative retained losses of
the Company at the reporting date.
The notes to the financial statements form an integral part of
these financial statements.
Statement of Cash Flows
Note 2017 2016
GBP GBP
Cash Flows from Operating
Activities
Loss before taxation (177,149) (46,077)
Adjustments for:
Loss on disposal of available
for sale financial assets 6 9,679 -
Share based payment 10 7,191 -
Changes in working capital:
(Increase)/Decrease in trade
and other receivables (37,867) 36,147
Increase/(Decrease) in trade
and other payables 23,025 (5,750)
_____ _____
Net Cash used in Operating
Activities (175,121) (15,680)
_____ _____
Cash Flows from Investing
Activities
Purchase of available for
sale financial assets 6 - (37,500)
Proceeds from sale of available
for sale financial assets 10,321 25,000
______ ______
Net Cash generated from/(used
in) Investing Activities 10,321 (12,500)
______ ______
Cash Flows from Financing
Activities
Proceeds from issue of shares, 720,837 -
net of issue costs
______ ______
Net Cash generated from Financing 720,837 -
Activities
______ ______
Net Increase/(Decrease) in
Cash and Cash Equivalents 556,037 (28,180)
Cash and cash equivalents
at the beginning of the year 37,369 65,549
_______ _______
Cash and Cash Equivalents
at the End of the Year 593,406 37,369
_______ _______
There were no major non-cash transactions during 2016 or
2017.
The notes to the financial statements form an integral part of
these financial statements.
Notes to the Financial Statements
1. General Information
The Company was incorporated in the UK on 20 April 2011 as a
public limited company with the name Black Lion Capital Plc. The
Company subsequently changed its name to Black Eagle Capital Plc on
13 September 2011 and on 15 November 2016 changed its name to
Dukemount Capital Plc. On 29 March 2017 the Company was admitted to
the London Stock exchange by way of a standard listing.
The Company's principal activity is to acquire, manage, develop
and, where appropriate on-sell, real estate portfolios specialising
mainly in the supported living and hotels sector.
The Company's registered office is located at 50 Jermyn Street,
London SW1Y 6LX.
2. Summary of Significant Accounting Policies
The principal accounting policies applied in the preparation of
these financial statements are set out below. These policies have
been consistently applied to all the years presented, unless
otherwise stated.
a) Basis of Preparation
The financial statements have been prepared in accordance with
EU-endorsed International Financial Reporting Standards (IFRS),
IFRIC interpretations and the parts of the Companies Act 2006
applicable to Companies reporting under IFRS. The financial
statements have also been prepared under the historical cost
convention, as modified by the revaluation of available for sale
financial assets at fair value.
The preparation of financial statements in conformity with IFRSs
requires the use of certain critical accounting estimates. It also
requires management to exercise its judgement in the process of
applying the Company's Accounting Policies. The areas involving a
higher degree of judgement or complexity, or areas where
assumptions and estimates are significant to the financial
statements, are disclosed later in these accounting policies.
The financial statements are presented in Pound Sterling (GBP),
rounded to the nearest pound.
i) New and Amended Standards mandatory for the first time for the period beginning 1 May 2016
No new standards, amendments or interpretations, effective for
the first time for the financial year beginning on or after 1 May
2016 have had a material impact on the Company. The standards,
amendments and interpretations considered were as follows:
Standard Impact on initial application Effective
date
Clarification of acceptable
IAS 16 & IAS methods of depreciation 1 January
38 (Amendments) and amortisation 2016
IAS 27 (Amendments) Equity method in separate 1 January
financial statements 2016
IAS 28 (Amendments) Investments in associates 1 January
and joint ventures 2016
IAS 28 & IFRS Investment entities: applying 1 January
1 (Amendments) the consolidation exemption 2016
IAS 1 (Amendments) Disclosure initiative 1 January
2016
Notes to the Financial Statements
2. Summary of Significant Accounting Policies (continued)
a) Basis of Preparation (continued)
ii) New standards, amendments and Interpretations in issue but not yet effective or not yet endorsed and not early adopted
The standards and interpretations that are issued, but not yet
effective, up to the date of issuance of the financial statements
are listed below. The Company intend to adopt these standards, if
applicable, when they become effective.
Standard Impact on initial application Effective date
IFRS 9 (Amendments) Financial Instruments 1 January 2018
IFRS 15 Revenue from contracts with customers 1 January 2018
IFRS 16 Leases *1 January 2018
IFRS 2 (Amendments) Share-based payments - classification and measurement *1 January 2018
2014-2016 Cycle *1 January 2018
Annual improvements Foreign currency transactions and advanced consideration
IFRIC Interpretations 22 Foreign currency transactions and advance considerations 1 January 2018
IAS 40 (Amendments) *1 January 2018
(*) Subject to EU endorsement
IFRS 9, 'Financial instruments', addresses the classification,
measurement and recognition of financial assets and financial
liabilities. The complete version of IFRS 9 was issued in July
2014. It replaces the guidance in IAS 39 that relates to the
classification and measurement of financial instruments. IFRS 9
retains but simplifies the mixed measurement model and establishes
three primary measurement categories for financial assets:
amortised cost, fair value through other comprehensive income and
fair value through profit and loss. The basis of classification
depends on the entity's business model and the contractual cash
flow characteristics of the financial asset. Investments in equity
instruments are required to be measured at fair value through
profit or loss with the irrevocable option at inception to present
changes in fair value in other comprehensive income. There is now a
new expected credit losses model that replaces the incurred loss
impairment model used in IAS 39. For financial liabilities there
were no changes to classification and measurement except for the
recognition of changes in own credit risk in other comprehensive
income, for liabilities designated at fair value through profit or
loss. IFRS 9 relaxes the requirements for hedge effectiveness by
replacing the bright line hedge effectiveness tests. It requires an
economic relationship between the hedged item and hedging
instrument and for the 'hedged ratio' to be the same as the one
management actually use for risk management purposes The standard
is effective for accounting periods beginning on or after 1 January
2018 but early adoption is permitted.
As at 30 April 2017, the Company only holds available for sale
financial assets and basic financial instruments such as loans and
receivables and other liabilities measured at amortised cost. The
Directors believe the potential changes caused by IFRS 9 are
unlikely to be material until the business develops and completes a
transaction. The Directors do not intend to early adopt this
standard.
Notes to the Financial Statements
2. Summary of Significant Accounting Policies (continued)
b) Significant accounting judgements, estimates and assumptions
The principal area in which judgement is applied is as
follows:
Going concern
The preparation of financial statements requires an assessment
on the validity of the going concern assumption.
The Directors have reviewed projections for a period of at least
12 months from the date of approval of the Financial Statements.
The Company has no revenues but significant cash resources were
raised, following its listing, to finance its activities whilst it
identifies and completes suitable transaction opportunities.
In making their assessment of going concern, the Directors
acknowledge that the Company has a very small cost base and can
therefore confirm that they hold sufficient funds to ensure the
Company continues to meet its obligations as they fall due for a
period of at least one year from date of approval of these
Financial Statements. Accordingly, the Board believes it is
appropriate to adopt the going concern basis in the preparation of
the Financial Statements.
c) Financial Instruments
Financial assets
Financial assets, comprising solely of other receivables and
cash and cash equivalents, are classified as loans and receivables
held at amortised cost.
Other financial assets, being available for sale financial
assets, are classified as available for sale. This classification
is determined at initial recognition and depends on the purpose for
which the financial assets were acquired. These assets are
non-derivative financial assets either designated as such or not
classifiable under any of the other categories. They are included
under current assets as management intends to dispose of the
investments within 12 months of the end of the reporting period,
where it is in the Company's best interests to do so.
Available for sale financial assets are initially recognised at
fair value plus transaction costs. Financial assets are
derecognised when the rights to receive cash flows from the assets
have expired or have been transferred, and the Company has
transferred substantially all of the risks and rewards of
ownership.
Available for sale financial assets are subsequently carried at
fair value unless the Company is precluded from doing so as, in the
case of unlisted equity securities, the range of reasonable fair
value estimates is significant and the probabilities of the various
estimates cannot be reasonably assessed. In such circumstances
available-for-sale financial assets are held at cost and reviewed
annually for impairment. Loans and receivables are subsequently
carried at amortised cost using the effective interest method.
Changes in the fair value of monetary and non-monetary
non-derivative financial assets classified as available for sale
are recognised in other comprehensive income. When such financial
assets classified as available for sale are sold or impaired, the
accumulated fair value adjustments recognised in equity are
included in profit or loss as net "gains/(losses) from disposal of
available for sale financial assets."
Notes to the Financial Statements
2. Summary of Significant Accounting Policies (continued)
c) Financial instruments (continued)
Dividends on available-for-sale equity instruments are
recognised in profit or loss as part of other income when the
Company's right to receive payments is established.
The Company assesses at the end of each reporting period whether
there is objective evidence that a financial asset, or a group of
financial assets, is impaired. A financial asset, or a group of
financial assets, is impaired, and impairment losses are incurred,
only if there is objective evidence of impairment as a result of
one or more events that occurred after the initial recognition of
the asset (a "loss event"), and that loss event (or events) has an
impact on the estimated future cash flows of the financial asset,
or group of financial assets, that can be reliably estimated.
The criteria that the Company uses to determine that there is
objective evidence of an impairment loss include:
-- significant financial difficulty of the issuer or obligor;
-- a breach of contract, such as a default or delinquency in interest or principal repayments;
-- the disappearance of an active market for that financial
asset because of financial difficulties;
-- observable data indicating that there is a measureable
decrease in the estimated future cash flows from a portfolio of
financial assets since the initial recognition of those assets,
although the decrease cannot yet be identified with the individual
financial assets in the portfolio; or
-- for assets classified as available-for-sale, a significant or
prolonged decline in fair value of the security below its cost.
For loans and receivables, the amount of the impairment loss is
measured as the difference between the asset's carrying amount and
the present value of estimated future cash flows (excluding future
credit losses that have not been incurred), discounted at the
financial asset's original effective interest rate. The asset's
carrying amount is reduced, and the loss is recognised in profit or
loss.
If, in a subsequent period, the amount of the impairment loss
decreases and the decrease can be related objectively to an event
occurring after the impairment was recognised (such as an
improvement in the debtor's credit rating), the reversal of the
previously recognised impairment loss is recognised in profit or
loss.
For assets classified as available-for-sale, the Company
assesses at each reporting period whether there is objective
evidence that a financial asset is impaired. In the case of equity
investments classified as available-for-sale, a significant or
prolonged decline in the fair value of the security below its cost
is one example that the asset is impaired. If any such evidence
exists for available-for-sale financial assets, the cumulative
loss, measured as the difference between the acquisition cost and
the current fair value, less any impairment loss on the financial
previously recognised in profit or loss, is removed from equity and
recognised in profit or loss. Impairment losses recognised in
profit or loss on equity instruments are not reversed through
profit or loss.
Financial liabilities
Financial liabilities, comprising trade and other payables, are
held at amortised cost.
Trade payables are obligations to pay for goods or services that
have been acquired in the ordinary course of business from
suppliers. Accounts payable are classified as current liabilities
if payment is due within one year or less. If not, they are
presented as non-current liabilities.
Trade and other payables are recognised initially at fair value,
and subsequently measured at amortised cost using the effective
interest method.
Notes to the Financial Statements
d) De-recognition of Financial Instruments
i. Financial Assets
A financial asset is derecognised where:
-- the right to receive cash flows from the asset has expired;
-- the Company retains the right to receive cash flows from the
asset, but has assumed an obligation to pay them in full without
material delay to a third party under a pass-through arrangement;
or
-- the Company has transferred the rights to receive cash flows
from the asset, and either has transferred substantially all the
risks and rewards of the asset or has neither transferred nor
retained substantially all the risks and rewards of the asset, but
has transferred control of the asset.
ii. Financial Liabilities
A financial liability is derecognised when the obligation under
the liability is discharged or cancelled or expires. Where an
existing financial liability is replaced by another from the same
lender on substantially different terms, or the terms of an
existing liability are substantially modified, such an exchange or
modification is treated as a derecognition of the original
liability and the recognition of a new liability, and the
difference in the respective carrying amounts is recognised in the
statement of comprehensive income.
e) Cash and Cash Equivalents
Cash and cash equivalents comprise cash in hand and current and
deposit balances with banks and similar institutions. This
definition is also used for the Statement of Cash Flows.
The Company considers the credit ratings of banks in which it
holds funds in order to reduce exposure to credit risk. The Company
will only keep its holdings of cash and cash equivalents with
institutions which have a minimum credit rating of 'AA-'.
The Company considers that it is not exposed to major
concentrations of credit risk.
f) Taxation
Current tax
Current tax is the tax currently payable based on the taxable
profit for the year. Tax is recognised in profit or loss, except to
the extent that it relates to items recognised in other
comprehensive income or recognised in equity. In this case, the tax
is also recognised in other comprehensive income or directly in
equity, respectively.
Current tax is calculated at the tax rates (and laws) that have
been enacted or substantively enacted at the Statement of Financial
Position date.
Deferred tax
Deferred tax is recognised using the liability method in respect
of temporary differences arising from differences between the
carrying amount of assets and liabilities in the Financial
Statements and the corresponding tax bases used in the computation
of taxable profit. However, deferred tax is not accounted for if it
arises from initial recognition of an asset or liability in a
transaction that at the time of the transaction affects neither
accounting nor taxable profit or loss. In principle, deferred tax
liabilities are recognised for all taxable temporary differences
and deferred tax assets are recognised to the extent that it is
probable that taxable profits will be available against which
deductible temporary differences can be utilised.
Notes to the Financial Statements
f) Taxation (continued)
Deferred tax assets and liabilities are offset when there is a
legally enforceable right to offset current tax assets against
current tax liabilities and when the deferred tax assets and
liabilities relate to income taxes levied by the same taxation
authority on either the same taxable entity or different taxable
entities where there is an intention to settle the balances on a
net basis.
Deferred tax is calculated at the tax rates (and laws) that have
been enacted or substantively enacted at the Statement of Financial
Position date and are expected to apply to the period when the
deferred tax asset is realised or the deferred tax liability is
settled.
Deferred tax assets and liabilities are not discounted.
g) Segmental reporting
Identifying and assessing investment projects is the only
activity the Company is involved in and is therefore considered as
the only operating/reportable segment.
Therefore the financial information of the single segment is the
same as that set out in the Company Statement of Comprehensive
Income, Statement of Financial Position, Statement of Changes in
Equity and the Company Statement of Cashflows.
h) Equity
Equity comprises the following:
-- Share capital representing the nominal value of the equity shares;
-- Share Premium representing consideration less nominal value
of issued shares and costs directly attributable to the issue of
new shares;
-- Share based payments reserve representing the fair value of
share based payments valued in accordance with IFRS 2;
-- Retained earnings representing retained losses, and the
accumulated fair value adjustments on available-for-sale financial
assets that are not permanently impaired.
i) Share Capital
Ordinary shares are classified as equity.
j) Share Based Payments
The Company has issued warrants over the ordinary share capital
as described in note 10. In accordance with IFRS 2, the total
amount to be expensed over the vesting period for warrants issued
for services is determined by reference to the fair value of the
warrants granted, excluding non--market vesting conditions.
Non--market vesting conditions are included in assumptions about
the number of warrants that are expected to vest.
For warrants issued relating to the raising of finance, the
relevant expense is offset against the share premium account. The
total amount to be expensed is determined by reference to the fair
rate of the options and warrants granted, excluding non--market
vesting conditions. Non--market vesting conditions are included in
assumptions about the number of warrants that are expected to
vest.
Notes to the Financial Statements
k) Financial Risk Management
Financial Risk Factors
The Company's activities expose it to a variety of financial
risks: market risk (price risk), credit risk and liquidity risk.
The Company's overall risk management programme seeks to minimise
potential adverse effects on the Company's financial performance.
None of these risks are hedged.
The Company has no foreign currency transactions or borrowings,
so is not exposed to market risk in terms of foreign exchange risk
or interest rate risk.
Risk management is undertaken by the Board of Directors.
Market Risk - price risk
The Company is exposed to equity securities price risk because
of investments held by the Company, classified as
available-for-sale financial assets. These assets' carrying value
at the year end is GBP25,000 which represents the maximum exposure
for the Company.
The Company is not exposed to commodity price risk. The
Directors will revisit the appropriateness of this policy should
the Company's operations change in size or nature.
Some of the Company's investments in equity of other entities
are publicly traded and are listed on the London Stock Exchange and
Alternative Investment Market (AIM). There is a limited volume of
shares traded in these companies and if a significant disposal of
the shares was made by the Company, this could have a significant
impact on the realisable value of their shares. The table below
summarises the potential impact of increases/decreases in the
market price on the Company's result for the year and on equity.
The analysis is based on the assumption that the share prices have
increased/decreased by 5% with all other variables held constant
and all the Company's equity instruments moved according to the
historical correlation with the market:
Profit/(Loss) Other
for the year comprehensive income
Potential impact on: 2017 2016 2017 2016
Listed Investments (Level 1) GBP GBP GBP GBP
Available-for-sale financial assets - 5% increase - - - 100
Available-for-sale financial assets - 5% decrease - - - (100)
____ ___ ____ ____
There is no impact at the year end as all level 1 investments
had been disposed of in the year and fair value losses recognised
in profit or loss.
The Company also has investments in equity of other entities
that are listed but currently suspended and are therefore valued in
accordance with tier 3 of the fair value hierarchy. Management
tests annually whether the investments have future economic value
in accordance with the accounting policies. These valuations are
based on management's estimates using all information available to
them, some of which may be historic. The realised value from the
sale of these assets may be different to those stated. A 5%
increase/decrease movement in valuation would have the following
impact:
Notes to the Financial Statements
k) Financial Risk Management (continued)
Profit/(Loss) Other
for the comprehensive
year income
Potential impact on: 2017 2016 2017 2016
Unlisted Investments (Level GBP GBP GBP GBP
3)
Available-for-sale financial
assets - 5% increase - - 1,250 1,250
Available-for-sale financial
assets - 5% decrease - - (1,250) (1,250)
____ ___ ____ ____
Losses for the year would increase/decrease as a result of
gains/losses on equity securities classified as at fair value
through profit or loss. Other components of equity would
increase/decrease as a result of gains/losses on equity securities
classified as available for sale.
Credit risk
Credit risk arises from cash and cash equivalents as well as any
outstanding receivables. Management does not expect any losses from
non-performance of these receivables. The amount of exposure to any
individual counter party is subject to a limit, which is assessed
by the Board.
The Company considers the credit ratings of banks in which it
holds funds in order to reduce exposure to credit risk, which is
stated under the cash and cash equivalents accounting policy.
Liquidity risk
Liquidity risk arises from the Company's management of working
capital. It is the risk that the Company will encounter difficulty
in meeting its financial obligations as they fall due. The proceeds
raised from the placing are being held as cash to enable the
Company to fund a transaction as and when a suitable target is
found.
Controls over expenditure are carefully managed, in order to
maintain its cash reserves whilst it targets a suitable
transaction.
Financial liabilities are all due within one year.
Capital risk management
The Company's objectives when managing capital is to safeguard
the Company's ability to continue as a going concern, in order to
provide returns for shareholders and benefits for other
stakeholders, and to maintain an optimal capital structure. The
Company has no borrowings.
In order to maintain or adjust the capital structure, the
Company may adjust the amount of dividends paid to shareholders,
return capital to shareholders or issue new shares.
The Company monitors capital on the basis of the total equity
held by the Company, being GBP633,324 as at 30 April 2017 (2016:
GBP64,445).
Notes to the Financial Statements
l) Fair Value Estimation
The table below analyses financial instruments carried at fair
value, by valuation method. The level at which a financial
instrument can be defined is as follows:
-- Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1);
-- Inputs other than quoted prices included within Level 1 that
are observable for the asset or liability, either directly (that
is, as prices) or indirectly (that is, derived from prices) (Level
2); and
-- Inputs for the asset or liability that are not based on
observable market data (that is, unobservable inputs) (Level
3).
The following table presents the Company's financial assets that
are measured at fair value.
2017 2016
Assets Level 1 Level 3 Total Level 1 Level 3 Total
GBP GBP GBP GBP GBP GBP
Available-for-sale financial assets - 25,000 25,000 2,000 25,000 27,000
______ ______ ______ ______ ______ ______
Total assets - 25,000 25,000 2,000 25,000 27,000
______ ______ ______ ______ ______ ______
The Investment in Red Leopard Holdings Plc, which was disposed
of in the year, was quoted in an active market, and is classified
as a Level 1 in the table above.
The investment in Silver Falcon Plc is quoted but currently
suspended, and is classified as Level 3 in the table above. See
note 2(m) for further detail.
The fair value of financial instruments traded in active markets
is based on quoted market prices at the end of the reporting
period. A market is regarded as active if quoted prices are readily
and regularly available from an exchange, dealer, broker, industry
group, pricing service or regulatory agency, and those prices
represent actual and regularly occurring market transactions on an
arm's length basis. The quoted market price used for financial
assets held by the Company is the current bid price. These
instruments are included in Level 1. Instruments included in Level
1 comprise primarily AIM quoted equity investments classified as
trading securities or available-for-sale. The fair values of quoted
investments are based on current bid prices.
The fair value of financial instruments that are not traded in
an active market is determined by using valuation techniques. These
valuation techniques maximise the use of observable market data
where it is available, and rely as little possible on
entity-specific estimates. If all significant inputs required to
fair value an instrument are observable, the instrument is included
in Level 2. If one or more of the significant inputs is not based
on observable market data, the instrument is included in Level
3.
Specific valuation techniques used to value financial
instruments include:
-- quoted market prices or dealer quotes for similar instruments;
-- other techniques, such as discounted cash flow analysis or
the last available quoted market price are used to determine fair
value for the remaining financial instruments.
Notes to the Financial Statements
l) Fair Value Estimation (continued)
The following table presents the changes in Level 1 instruments
for the period ended:
2017 2016
GBP GBP
Balance as at 1 May 2,000 8,400
Fair value profit/(loss) 800 (6,400)
Disposals of Level 1 (2,800) -
______ ______
Balance as at 30 April - 2,000
______ ______
The following table presents the changes in Level 3 instruments
for the period ended:
2017 2016
GBP GBP
Balance as at 1 May 25,000 50,000
Disposals of Level 3 - (25,000)
______ ______
Balance as at 30 April 25,000 25,000
______ ______
m) Critical Accounting Estimates
The Directors make estimates and assumptions concerning the
future as required by the preparation of the financial statements
in conformity with EU endorsed IFRSs. The resulting accounting
estimates will, by definition, seldom equal the related actual
results.
Estimates and judgements are continually evaluated and are based
on historical experience and other factors, including expectations
of future events that are believed to be reasonable under the
circumstances
i) In accordance with IFRS 2 'Share Based Payments' the Company
has recognised the fair value of warrants calculated using the
Black-Scholes option pricing model. The Directors have made
significant assumptions particularly regarding the volatility of
the share price at the grant date in order to reach a total fair
value of GBP30,499. Further information is disclosed in Note
10.
ii) Available for sale financial assets have a carrying value at
30 April 2017 of GBP25,000 (2016: GBP27,000). The Company holds
listed and unlisted equity securities as available-for-sale
financial assets.
The Company follows the guidance of IAS 39 to determine when an
available-for-sale financial asset is impaired. This determination
requires significant judgement. In making this judgement, the
Company evaluates, among other factors, the duration and extent to
which the fair value of an investment is less than its cost.
Management has concluded that there is no impairment charge
necessary to the carrying value of available for sale financial
assets.
The Company holds 2,500,000 Ordinary share of 1p each at par in
Silver Falcon Plc. Silver Falcon was listed on the FTSE All Share
Index of the London Stock Exchange on 9(th) November 2015. At the
year end the shares are suspended pending the completion of a
transaction and the Directors have taken the view that it would be
prudent to value the shares at cost even though the share price,
just prior to suspension, was more than three times greater than
the acquisition price the Company paid.
Notes to the Financial Statements
3. Taxation
Tax Charge for the Year
No taxation arises on the result for the year due to taxable
losses.
Factors Affecting the Tax Charge for the Period
The tax credit for the period does not equate to the loss for
the period at the applicable rate of UK Corporation Tax of 19.92%
(2016: 20%). The differences are explained below:
2017 2016
GBP GBP
Loss for the period before taxation (177,149) (46,077)
______ _____
Loss for the period before taxation
multiplied by the standard
rate of UK Corporation Tax of 19.92%
(2016: 20%) (35,284) (9,215)
Expenses not deductible for tax 3,426 -
purposes
Income not taxable for tax purposes (1,498) -
Losses carried forward on which
no deferred tax asset is recognised 33,356 9,215
______ _____
- -
______ _____
Factors Affecting the Tax Charge of Future Periods
Tax losses available to be carried forward by the Company at 30
April 2017 against future profits are estimated at GBP371,000 (2016
- GBP201,000).
A deferred tax asset has not been recognised in respect of these
losses in view of uncertainty as to the level of future taxable
profits.
4. Dividends
No dividend has been declared or paid by the Company during the
year ended 30 April 2017 (2016: Nil).
5. Earnings per share
Basic earnings per share is calculated by dividing the loss
attributable to equity holders of the Company by the weighted
average number of ordinary shares in issue during the year. In
accordance with IAS 33, basic and diluted earnings per share are
identical as the effect of the exercise of the warrants would be to
decrease the loss per share.
2017 2016
Loss attributable to equity holders of the Company 177,149
46,077
______ ______
Total GBP177,149 GBP46,077
______ ______
Weighted average number of ordinary shares in issue (thousands)
179,687 152,500
______ ______
Notes to the Financial Statements
6. Available for sale financial assets
2017 2016
GBP GBP
At beginning of period 27,000 58,400
Disposals (2,800) (25,000)
Fair value profit/(loss) 800 (6,400)
______ ______
At End of Period 25,000 27,000
Less: non-current portion - -
______ ______
Current Portion 25,000 27,000
______ ______
As at 30 April 2017 all available for sale financial assets
comprise UK Equity securities denominated in GBP Sterling.
During 2014 the Company acquired an investment of less than 2%
in Red Leopard Holdings Plc for GBP25,000. Red Leopard Holdings Plc
is a UK based investment company, listed on AIM, which focuses on
investments in the natural resources sector, such as precious
metals. On 30 October 2013, the Company divested off 20% of the
original investment for GBP6,451. On 6 March 2017 the Company sold
its remaining holding for GBP10,321, resulting in a profit on
disposal of GBP7,521. On disposal, cumulative losses of GBP17,200
previously recognised in other comprehensive income have been
reclassified to profit or loss. This has given a net loss of
GBP9,679 recognised in the profit or loss in the year.
The Company holds 2,500,000 Ordinary share of 1p each at par in
Silver Falcon Plc. Silver Falcon was listed on the FTSE All Share
Index of the London Stock Exchange on 9(th) November 2015. At the
year end, the shares are suspended pending the completion of a
transaction and as such the Directors have taken the view that it
would be prudent to value the shares at cost even though the share
price, just prior to suspension, was more than three times greater
than the acquisition price the Company paid.
Further details on the Directors' assessment of the fair value
at 30 April 2017 is explained under Critical Accounting Estimates
set out under the Accounting Policies which are disclosed before
the notes to the Financial Statements.
7. Trade and Other Receivables
2017 2016
GBP GBP
Other receivables, including prepayments 41,793 3,926
_____ _____
The fair value of all receivables is the same as their carrying
values stated above.
At 30 April 2017 all receivables were fully performing, and
therefore do not require impairment.
The maximum exposure to credit risk at the reporting date is the
carrying value mentioned above. The Company does not hold any
collateral as security.
Notes to the Financial Statements
8. Share Capital
2017 2016
No No
Allotted, issued and fully paid (000's) (000's)
338,300,000 ordinary shares of GBP0.001
each 338,300 152,500
_______ _______
On 9 January 2017 the Company raised gross proceeds of GBP48,000
via the issue and allotment of 48,000,000 new ordinary shares at
par value of GBP0.001.
On 29 March 2017, at the time the Company was admitted to the
Official List of the UK Listing Authority, the Company raised gross
proceeds of GBP137,800 via the issue and allotment of 137,800,000
new ordinary shares at par value of GBP0.001. On the same date,
warrants over 8% of the share capital at that time at an exercise
price of 0.5 pence for a term of three years from Admission were
issued to Chesterfield Capital of which Geoffrey Dart is a director
and indirect shareholder. Also at that time warrants over 1,032,000
ordinary shares and 972,000 ordinary shares at an exercise price of
0.75 pence and for a three year term were issued to Optiva
Securities Ltd and Peterhouse Corporate Finance respectively. These
warrants have all been recognised in the profit or loss.
At the Annual General Meeting of the Company on 3 October 2016,
the exercise period of the previously issued 5 year warrants was
extended by a further five years to 8 September 2021. See note 10
for the IFRS 2 considerations with regards to this modification.
These warrants now consist of:
Warrants for 2% of the Ordinary Share capital of the Company at
the date of admission were issued to Mr Peter Redmond at a price of
0.5 pence per Ordinary Share with a further lifespan of 5 years.
These were included in profit or loss at the time of issue.
Warrants for 15% of the Ordinary Share capital at the date of
exercise, with the same cap on issued Ordinary Share capital at
exercise for calculation purposes as had been the case for the
previously issued warrants (being the number of ordinary shares in
issue at the date on which the Company was listed in 2011), were
issued to Mr Bryan Dart and Continental National Resources Limited.
The price of the newly issued warrants is 0.5 pence for the
proportion of Ordinary Shares issued that relate to the number of
Ordinary Shares in issue at the date of Admission and the price of
the latest share issue prior to the exercise of the warrants for
the remainder. These were included in profit or loss at the time of
issue.
9. Share Premium
Share Premium Less share Net Share
GBP issue costs Premium
GBP GBP
At 1 May 2016 196,500 - 196,500
Placing 29 March 2017 623,200 (88,163) 535,037
_______ ______ _______
At 30 April 2017 819,700 (88,163) 731,537
_______ ______ _______
Notes to the Financial Statements
10. Share Based Payments
As explained in note 8, there were warrants issued which were
outstanding and exercisable at the end of the period.
The expiry date of the warrants is 8 September 2021 and 29 March
2020. The exercise price of the warrants is GBP0.005 and GBP0.0075.
The Company has no legal or constructive obligation to settle or
repurchase the warrants in cash. The fair value of the warrants was
determined using the Black Scholes valuation model. The parameters
used are detailed below:
Various dates
between 8
September
2011 and At At
Warrant granted 26 October 29 March 29 March
on: 2011 2017 2017
Warrant life 5 years* 3 years 3 years
(years)
Warrants granted 25,925,000 27,064,000 2,004,000
Risk free rate 2.2% 0.5% 0.5%
Exercise price
(GBP) 0.005 0.005 0.0075
Expected volatility 20% 20% 20%
Expected dividend - - -
yield
Marketability
discount 20% 20% 20%
Total fair value
of warrants granted
(GBP) 23,308 7,125 66
*Warrants extended for a further 5 years to 8 September
2021.
The expected volatility for the warrants granted is based on the
historical share price volatility of similar listed entities from
their date of admission to the market up to the completion of the
first six months of trading. This is considered to be the most
reasonable measure of expected volatility, given the relatively
brief trading history of the Company.
The warrants issued in 2011 have been modified in the year, with
their expiry date being extended until 8 September 2021. The fair
value adjustment as required under IFRS 2 as a result of this
modification was immaterial and as such no change in the fair value
has been reflected in the Financial Statements.
The risk free rate of return is based on zero yield government
bonds for a term consistent with the warrant life. A reconciliation
of warrants granted over the period to 30 April 2017 is shown
below:
Weighted average
exercise price
Number (GBP)
As at 1 May 2016 25,925,000 -
Granted 29,068,000 0.005
_________ _____
Outstanding as at 30 April
2017 54,993,000 0.005
_________ _____
Exercisable at 30 April 2017 54,993,000 0.005
_________ _____
The weighted average contracted and expected life (years) for
the above warrants is 4 years (2016 - 0.5 years).
Notes to the Financial Statements
11. Expenses by Nature
2017 2016
GBP GBP
Directors' fees 32,500 -
Establishment costs 8,581 12,350
Legal and professional fees 54,058 33,575
Listing/ regulatory costs 61,396 -
Travel and accommodation 2,207 -
Share option charge 7,191 -
Other expenses 1,537 152
______ ______
Total Administrative Expenses 167,470 46,077
______ ______
12. Services provided by the Company's Auditors
During the year, the Company obtained the following services
from the Company's auditors and its associates:
2017 2016
GBP GBP
Fees payable to the Company's auditor
and its associates for the audit
of the Company Financial Statements 10,000 2,825
Fees payable to the Company's auditor
for tax compliance and other
Services 1,000 750
Fees payable to the Company's auditor
for corporate finance work in relation
to the listing 10,000 -
______ ______
13. Directors' Remuneration
2017 2016
GBP GBP
Geoffrey Dart 12,500 -
Timothy Le Druillenec 10,000 -
Peter Redmond (resigned 26 April
2017) 10,000 -
_____ ______
Total 32,500 -
______ ______
There are no other employees of the Company.
14. Trade and Other Payables
2017 2016
GBP GBP
Accruals 26,875 3,850
______ ______
15. Treasury Policy and Financial Instruments
The Company operates an informal treasury policy which includes
the ongoing assessments of interest rate management and borrowing
policy. The Board approves all decisions on treasury policy.
The Company has financed its activities by the raising of funds
through the placing of shares.
There are no material differences between the book value and
fair value of the financial instruments.
Notes to the Financial Statements
16. Capital Commitments
There were no capital commitments authorised by the Directors or
contracted for at 30 April 2017.
17. Related Party Transactions
Silver Falcon Plc
As disclosed in note 6, the Company holds 2,500,000 Ordinary
shares of 1p each at par in Silver Falcon Plc. Silver Falcon was
listed on the FTSE All Share Index of the London Stock Exchange on
9(th) November 2015.
During the year the Company charged Silver Falcon Plc an amount
of GBP19,561 (2016: GBP9,578) in respect of office space utilised
on an ad hoc basis during the year. There was no balance
outstanding at the year end in respect of this transaction (2016:
GBPnil).
Geoffrey Dart and Peter Redmond are directors of Silver Falcon
Plc.
Briarmount Limited
During the year, the Company paid GBP46,591 (2016: GBP5,941) to
Briarmount in respect of consultancy and accountancy services. The
Company also paid GBP10,000 (2016: GBPNil) to Briarmount in
relation to Director's fees.
Timothy Le Druillenec is a director of Briarmount Limited.
Chesterfield Capital Limited
During the year, the Company paid GBP12,500 (2016: GBPNil) to
Chesterfield Capital Limited in respect of Director's fees. As at
the year end, GBPNil (2016: GBPNil) was owed to Chesterfield
Capital Limited.
Warrants of 27,064,000 were issued to Chesterfield Capital
Limited on 29 March 2017 at an exercise price of 0.5p for a term of
3 years from admission.
Geoffrey Dart is a director of Chesterfield Capital Limited.
Catalyst Corporate Consultants Limited
During the year, the Company paid GBP10,000 (2016: GBPNil) to
Catalyst Corporate Consultants Limited in respect of Director's
fees. As at the year end, GBPNil (2016: GBPNil) was owed to
Catalyst Corporate Consultants Limited.
Peter Redmond is a director of Catalyst Corporate Consultants
Limited.
18. Ultimate Controlling Party
The Directors believe there to be no ultimate controlling
party.
20. Copies of the Annual Report
Copies of the annual report will be available on the Company's
website at www.dukemountcapitalplc.com and from the Company's
registered office, Room 4, 1(st) Floor, 50 Jermyn Street, London,
SW1Y 6LX.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FR PMMITMBJBBFR
(END) Dow Jones Newswires
August 11, 2017 02:00 ET (06:00 GMT)
Dukemount Capital (LSE:DKE)
Historical Stock Chart
From Apr 2024 to May 2024
Dukemount Capital (LSE:DKE)
Historical Stock Chart
From May 2023 to May 2024